Showing results (1971-1980 of 2,175) with videos related to

Sort By:
Pageof 218
American Heart Journal|February 9, 2018
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trialPatrícia O Guimarães, Sergio Leonardi, Zhen Huang, et al.
Journal of the American College of Cardiology|February 27, 2016
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A Doll, Megan L Neely, Matthew T Roe, et al.
European Heart Journal. Acute Cardiovascular Care|February 21, 2016
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trialRalf E Harskamp, Robert M Clare, Giuseppe Ambrosio, et al.
The New England Journal of Medicine|November 11, 2020
An Outbreak of Covid-19 on an Aircraft CarrierMatthew R Kasper, Jesse R Geibe, Christine L Sears, et al.
European Journal of Heart Failure|July 6, 2022
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trialMichele Senni, Wendimagegn G Alemayehu, David Sim, et al.
European Heart Journal. Acute Cardiovascular Care|March 15, 2014
Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trialClaes Held, Pierluigi Tricoci, Zhen Huang, et al.
American Heart Journal|August 10, 2016
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trialAxel Åkerblom, Robert M Clare, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|June 24, 2017
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF TrialStephen J Greene, Adrian F Hernandez, Allison Dunning, et al.
Circulation. Heart Failure|September 15, 2016
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Stephen J Greene, Adrian F Hernandez, Jie-Lena Sun, et al.
Circulation|July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomesSana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
Pageof 218